Economic benefits of pioglitazone for treating patients with Type 2 diabetes
Academic Article
- Overview
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 2004
has subject area
- 1115 Pharmacology and Pharmaceutical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- 1402 Applied Economics (FoR)
- Health Policy & Services (Science Metrix)